ESC Study Group of Sports Cardiology Recommendations for participation in leisure-time physical activities and competitive sports for patients with hypertension

European Journal of Preventive Cardiology

Volumn 12, Issue 4, 2005, Pages 326-331

  Fagard, Robert H ^a   Björnstad, Hans H ^b   Býrjesson, Mats ^c   Carré, Franã§ois ^d   Deligiannis, Asterios ^e   Vanhees, Luc ^a,f  

^a KU LEUVEN DEPARTMENT OF REHABILITATION SCIENCES   (Belgium)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^e ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^f Department of Rehabilitation ^*  (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; POTASSIUM SPARING DIURETIC AGENT;

ATHLETE; BLOOD PRESSURE; CARDIOVASCULAR RISK; DEHYDRATION; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DIZZINESS; DOPING; DYSPNEA; ELECTROCARDIOGRAM; ELECTROLYTE DISTURBANCE; EXERCISE; HUMAN; HYPERTENSION; LEISURE; LIPOLYSIS; MALAISE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SPORT; THORAX PAIN;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; EUROPE; EXERTION; HUMANS; HYPERTENSION; LEISURE ACTIVITIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPORTS;

EID: 23944444305     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000174827.79645.f5     Document Type: Article

References (38)

1. Guidelines Committee. 2003 European Society ofHypertension, European Society of Cardiology guidelines for the managementof arterial hypertension. J Hypertens 2003; 21: 1011–1053. http://www.eshonline.org/documents/2003_guidelines.pdf.
2. McKearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis ofworldwide data. Lancet 2005; 365: 217–223.
3. Verdecchia P. Prognostic value of ambulatory blood pressure:Current evidence and clinical implications. Hypertension 2000; 35: 844–851.
4. Celis H, Fagard RH. White-coat hypertension: A clinicalreview. Eur J Intern Med 2004; 15: 348–357.
5. Kouidi E, Fahadidou A, Tassoulas E, Deligiannis A, Coats A. White-coat hypertension detected duringscreening of male adolescent athletes. Am JHypertens 1999; 12: 223–226.
6. Björklund K, Lind L, Zethelius B, Andren B, Lithell H. Isolated ambulatory hypertension predictscardiovascular morbidity in elderly men. Circulation 2003; 107: 1297–1302.
7. Prospective Studies Collaboration. Age-specificrelevance of usual blood pressure to vascular mortality: A meta-analysis ofindividual data for one million adults in 61 prospectivestudies. Lancet 2002; 360: 1903–1913.
8. Fagard RH, Celis H. Prognostic significance of variouscharacteristics of out-of-the-office blood pressure. J Hypertens 2004; 22: 1663–1666.
9. Blood Pressure Lowering Treatment Trialists'Collaboration. Effects of different bloodpressure-lowering regimens on major cardiovascular events: Results ofprospectively designed overviews of randomized trials. Lancet 2003; 362: 1527–1535.
10. EUROASPIRE II Study Group. Lifestyle and riskfactor management and use of drug therapies in coronary patients from 15countries. Principal results from EUROASPIRE II Euro Heart SurveyProgramme. Eur Heart J 2001; 22: 554–572.
11. Fagard RH, Van den Enden M, Leeman M, Warling X. Survey on treatment of hypertension andimplementation of WHO/ISH risk stratification in primary care inBelgium. J Hypertens 2002; 20: 1297–1302.
12. Practice Guidelines Writing Committee. Practiceguidelines for primary care physicians: 2003 ESH/ESC HypertensionGuidelines. J Hypertens 2003; 21: 1779–1786. http://www.eshonline.org/documents/2003_hypertension_practice_guidelines.pdf.
13. O'Brien Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, et al. European Society of HypertensionRecommendations for conventional, ambulatory and home blood pressuremeasurement. J Hypertens 2003; 21: 821–848.
14. Deligiannis A. Cardiac side effects ofanabolics. Osterr J Sports Med 2002; 2: 35–37.
15. Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects of non-steroidalanti-inflammatory drugs on blood pressure. ArchIntern Med 1993; 153: 477–484.
16. Whelton A, White WB, Bello AE, Puma JA, Fort JG, SUCCESS-VII Investigators. Effects of celecoxiband rofecoxib on blood pressure and oedema in patients ≧ 65 yearsof age with systemic hypertension and osteoarthritis. Am J Cardiol 2002; 90: 959–963.
17. De Backer G, Ambrosioni E, Borck-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovasculardisease prevention in clinical practice. Eur Heart J 2003; 24: 1601–1610.
18. Lewis JF, Spirito P, Pelliccia A, Maron BJ. Usefulness of Doppler echocardiographicassessment of diastolic filling in distinguishing‘athlete's heart’ from hypertrophiccardiomyopathy. Br Heart J 1992; 68: 296–300.
19. Pluim BM, Zwindermans AH, van der Laarse A, van der Wall EE. The athlete's heart. A meta-analysisof cardiac structure and function. Circulation 1999; 100: 336–344.
20. Fagard RH. The athlete's heart. Heart 2003; 89: 1455–1461.
21. Bjørnstad H, Smith G, Storstein L, Meen HD, Hals O. Electrocardiographic and echocardiographicfindings in top athletes, athletic students and sedentary controlsubjects. Cardiology 1993; 82: 66–74.
22. Devereux RB, Bella J, Boman K, Gerdts E, Nieminen MS, Rokkedal J, et al. Echocardiographic left ventriculargeometry in hypertensive patients with electrocardiographic left ventricularhypertrophy. The LIFE study. Blood Pressure 2001; 10: 74–82.
23. Maron BJ, Roberts WC, McAllister HA, Rosing DR, Epstein SE. Sudden death in young athletes. Circulation 1980; 62: 218–229.
24. Basso C, Corrado D, Thiene G. Cardiovascular causes of sudden death in youngindividuals including athletes. Cardiol Rev 1999; 7: 127–135.
25. Corrado D, Pelliccia A, Bjørnstadt HH, Vanhees L, Biffi A, Borjesson M, et al. Cardiovascular pre-participationscreening of young competitive athletes for prevention of sudden death:proposal for a common European protocol. Eur Heart J 2005; 26: 516–524.
26. Virmani R, Burke AP, Farb A, Kark JA. Causes of sudden death in young and middle-agedcompetitive athletes. Cardiology Clinics 1997; 15: 439–472.
27. McLenachan JM, Henderson E, Morris KI, Dargie H. Ventricular arrhythmias in patients withhypertensive left ventricular hypertrophy. NEJM 1987; 317: 787–792.
28. Pelliccia A, Fagard R, Bjørnstad HH, Anastassakis A, Arbustini E, Assanelli D, et al. Recommendations for competitive sportsparticipation in athletes with cardiovascular disease. A consensus documentfrom the Study Group of Sports Cardiology of the Working Group of CardiacRehabilitation and Exercise Physiology, and the Working Group of Myocardialand Pericardial diseases of the European Society ofCardiology. European Heart Journal; doi:10.1093/eurheartj/ehi325.
29. Pescatello LS, Franklin B, Fagard R, Farquhar W, Kelley GA, Ray C. American College of Sports Medicine PositionStand: Exercise and Hypertension. Med Sci SportsExerc 2004; 36: 533–553.
30. Fagard RH, Pardaens K, Staessen JA, Thijs L. Should exercise blood pressure be measured inclinical practice? J Hypertens 1998; 16: 1215–1217.
31. Fagard R, Amery A. Physical exercise inhypertension. In: Laragh J Brenner editors, Hypertension: Pathophysiology, diagnosis andmanagement. Second edition. NewYork: Raven Press, 1995. pp.2669–2681.
32. Fagard RH. Physical activity, fitness and bloodpressure. In: Bulpitt CJ editor, Handbook of hypertension, Volume 20:Epidemiology of hypertension Amsterdam, TheNetherlands: Elsevier ScienceBV, 2000. pp.191–211.
33. Fagard RH. Exercise characteristics and the blood pressureresponse to dynamic physical training. Med SciSports Exerc 2001; 33(Suppl):S484–S492.
34. Whelton SP, Chin A, Xin X, He J. Effects of aerobic exercise on blood pressure: Ameta-analysis of randomised, controlled trials. AnnIntern Med 2002; 136: 493–503.
35. Cornelissen VA, Fagard RH. Effect of resistance training on resting bloodpressure: A meta-analysis of randomized controlled trials. J Hypertens 2005; 23: 251–259.
36. Van Baak MA. Hypertension, beta-adrenergic blocking agentsand exercise. Int J Sports Med 1994; 15: 112–115.
37. Vanhees L, Defoor J, Schepers D, Lijnen P, Peeters BY, Lacante PH, et al. Effects of bisoprolol and atenolol onendurance exercise capacity in healthy men. JHypertens 2000; 18: 35–43.
38. Vanhees L, Fagard R, Lijnen P, Amery A. Effect of antihypertensive medication onendurance exercise capacity in hypertensive sportsmen. J Hypertens 1991; 9: 1063–1068.